PRLH and obesity disorder: The main goal of this study was to examine whether our novel palmitoylated PrRP analog (palm11-PrRP31) could accomplish its potential anti-obesity and anti-diabetic effects in SHROB rats lacking leptin signaling and if its effect depends on functional leptin.